Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 22 articles: HTML format

Single Articles

March 2024
1. ATALLAH A, Grossman A, Nauman RW, Pare JF, et al
   Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
   Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
   PubMed     Abstract available
   
   
   September 2023
2. PRADHAN P, Jia G, Khankari NK, Zheng W, et al
   Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk.
   Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34736.
   PubMed     Abstract available
   
   
   
3. SJODAHL G, Eriksson P, Holmsten K, Abrahamsson J, et al
   Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
   Int J Cancer. 2023 Sep 6. doi: 10.1002/ijc.34715.
   PubMed     Abstract available
   
   
   August 2023
4. YU EY, Tang QY, Chen YT, Zhang YX, et al
   Genome-wide exploration of genetic interactions for bladder cancer risk.
   Int J Cancer. 2023 Aug 28. doi: 10.1002/ijc.34690.
   PubMed     Abstract available
   
   
   May 2023
5. HOSSEINI B, Zendehdel K, Bouaoun L, Hall AL, et al
   Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran.
   Int J Cancer. 2023 May 9. doi: 10.1002/ijc.34560.
   PubMed     Abstract available
   
   
   March 2023
6. HIEN TT, Ambite I, Wan MLY, Cavalera M, et al
   Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy.
   Int J Cancer. 2023 Mar 9. doi: 10.1002/ijc.34500.
   PubMed     Abstract available
   
   
   January 2023
7. VIDRA N, Beeren I, van Zutphen M, Aben KK, et al
   Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer.
   Int J Cancer. 2023 Jan 3. doi: 10.1002/ijc.34418.
   PubMed     Abstract available
   
   
   December 2022
8. EINERHAND SMH, van Dijk N, van Dorp J, de Feijter JM, et al
   Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
   Int J Cancer. 2022;151:2004-2011.
   PubMed     Abstract available
   
   
   November 2022
9. TAKAHASHI T
   Comments on "Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
   Int J Cancer. 2022;151:1847-1848.
   PubMed    
   
   
   
10. EINERHAND SMH, van Dijk N, van der Heijden MS, van Rhijn BWG, et al
    Reply to: Comments on "Neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
    Int J Cancer. 2022;151:1849-1850.
    PubMed    
    
    
    August 2022
11. KIM B, Jung M, Moon KC, Han D, et al
    Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34265.
    PubMed     Abstract available
    
    
    July 2022
12. XIONG J, Yang L, Deng YQ, Yan SY, et al
    The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study.
    Int J Cancer. 2022 Jul 29. doi: 10.1002/ijc.34228.
    PubMed     Abstract available
    
    
    February 2022
13. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies.
    Int J Cancer. 2022 Feb 19. doi: 10.1002/ijc.33970.
    PubMed     Abstract available
    
    
    January 2022
14. KARANOVIC S, Ardin M, Tang Z, Tomic K, et al
    Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure.
    Int J Cancer. 2022;150:374-386.
    PubMed     Abstract available
    
    
    September 2021
15. OLAH C, Hahnen C, Nagy N, Musial J, et al
    A qPCR-based method for molecular subtype classification of urinary bladder cancer - stromal gene expressions show higher prognostic values than intrinsic tumor genes.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33809.
    PubMed     Abstract available
    
    
    
16. LAI H, Cheng X, Liu Q, Luo W, et al
    Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
    Int J Cancer. 2021 Sep 3. doi: 10.1002/ijc.33794.
    PubMed     Abstract available
    
    
    March 2021
17. TREVISANI F, Di Marco F, Raggi D, Bettiga A, et al
    Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the pure-01 study.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33554.
    PubMed     Abstract available
    
    
    February 2021
18. VAN DOEVEREN T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, et al
    The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    Int J Cancer. 2021;148:981-987.
    PubMed     Abstract available
    
    
    January 2021
19. KOUTROS S, Decker KL, Baris D, Pardo LA, et al
    Bladder Cancer Risk Associated with Family History of Cancer.
    Int J Cancer. 2021 Jan 27. doi: 10.1002/ijc.33486.
    PubMed     Abstract available
    
    
    October 2020
20. OZGUN G, Senturk S, Erkek-Ozhan S
    Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33374.
    PubMed     Abstract available
    
    
    
21. WIECZOREK E, Garstka MA
    Recurrent Bladder Cancer in Aging Societies: Importance of Major Histocompatibility Complex Class I Antigen Presentation.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33359.
    PubMed     Abstract available
    
    
    June 2020
22. XU T, Li HT, Wei J, Li M, et al
    Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype.
    Int J Cancer. 2020;146:3065-3076.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.